VANCOUVER , May 5 / PRNewswire-FirstCall / - Response Biomedical Corporation ( TSX : RBM , OTCBB : RPBIF ) ( the " Company " ) today announced that it has filed a preliminary short form prospectus in each of the provinces and territories of Canada , other than Quebec , in respect of a marketed public offering ( the " Offering " ) of units ( the " Units " ) .